Log in

Dova Pharmaceuticals SEC Filings & 10K Form (NASDAQ:DOVA)

$28.04
0.00 (0.00 %)
(As of 11/12/2019)
Today's Range
$28.04
Now: $28.04
$28.04
50-Day Range
$27.97
MA: $28.09
$28.40
52-Week Range
$5.62
Now: $28.04
$28.54
Volume35,036 shs
Average Volume499,313 shs
Market Capitalization$807.55 million
P/E RatioN/A
Dividend YieldN/A
Beta2.74

SEC Filings

Dova Pharmaceuticals (NASDAQ:DOVA) SEC Filings

DateFilerForm TypeView
11/22/2019
3:12 PM
Dova Pharmaceuticals (Filer)
Form 15-12B
11/18/2019
11:15 PM
Dova Pharmaceuticals (Filer)
Form EFFECT
11/15/2019
7:02 PM
Dova Pharmaceuticals (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:42 PM
Dova Pharmaceuticals (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:41 PM
Dova Pharmaceuticals (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:40 PM
Dova Pharmaceuticals (Issuer)
Stalfort Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:39 PM
Dova Pharmaceuticals (Issuer)
Novak Alfred J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:38 PM
Dova Pharmaceuticals (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:36 PM
Dova Pharmaceuticals (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:35 PM
Dova Pharmaceuticals (Issuer)
Hoitt Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:34 PM
Dova Pharmaceuticals (Issuer)
Hahn Mark W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:33 PM
Dova Pharmaceuticals (Issuer)
Goldman Steven M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:32 PM
ALLEN LEE F MD PhD (Reporting)
Dova Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
8:43 AM
Dova Pharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
11/12/2019
8:34 AM
Dova Pharmaceuticals (Filer)
Form POS AM
11/12/2019
8:33 AM
Dova Pharmaceuticals (Filer)
Form S-8 POS
11/12/2019
8:32 AM
Dova Pharmaceuticals (Filer)
Form S-8 POS
11/12/2019
8:30 AM
Dova Pharmaceuticals (Subject)
Form SC 14D9/A
11/12/2019
8:25 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
8:19 AM
Dova Pharmaceuticals (Subject)
Swedish Orphan Biovitrum AB (0001789731) (Filed by)
Form SC TO-T/A
11/12/2019
5:05 AM
Dova Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2019
4:02 PM
Dova Pharmaceuticals (Subject)
Swedish Orphan Biovitrum AB (0001789731) (Filed by)
Form SC TO-T/A
10/11/2019
4:15 PM
Dova Pharmaceuticals (Subject)
Form SC 14D9
10/11/2019
4:08 PM
Dova Pharmaceuticals (Subject)
Swedish Orphan Biovitrum AB (0001789731) (Filed by)
Form SC TO-T
10/01/2019
4:12 PM
Dova Pharmaceuticals (Subject)
Swedish Orphan Biovitrum AB (0001789731) (Filed by)
Form SC TO-C
10/01/2019
10:03 AM
Dova Pharmaceuticals (Subject)
Swedish Orphpan Biovitrum AB (0001789731) (Filed by)
Form SC TO-C
09/30/2019
5:10 AM
Dova Pharmaceuticals (Subject)
Form SC14D9C
09/30/2019
5:09 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
3:05 PM
Dova Pharmaceuticals (Issuer)
Laliberte Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:15 PM
Dova Pharmaceuticals (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
6:14 AM
Dova Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:07 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
3:31 PM
Dova Pharmaceuticals (Issuer)
Laliberte Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:30 PM
ALLEN LEE F MD PhD (Reporting)
Dova Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2019
3:29 PM
Dova Pharmaceuticals (Issuer)
Hoitt Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
7:31 PM
Dova Pharmaceuticals (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2019
6:43 PM
Dova Pharmaceuticals (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
7:28 PM
Dova Pharmaceuticals (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:24 PM
Dova Pharmaceuticals (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:59 PM
Dova Pharmaceuticals (Issuer)
Hahn Mark W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:58 PM
Dova Pharmaceuticals (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:57 PM
Dova Pharmaceuticals (Issuer)
Laliberte Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:56 PM
ALLEN LEE F MD PhD (Reporting)
Dova Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:55 PM
Dova Pharmaceuticals (Issuer)
Hoitt Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
6:23 PM
Dova Pharmaceuticals (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:21 PM
Dova Pharmaceuticals (Issuer)
Goldman Steven M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
7:29 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
3:54 PM
Dova Pharmaceuticals (Issuer)
Goldman Steven M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
7:35 PM
Dova Pharmaceuticals (Issuer)
Goldman Steven M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
6:16 AM
Dova Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
6:12 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:35 PM
Dova Pharmaceuticals (Issuer)
Goldman Steven M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
3:34 PM
Dova Pharmaceuticals (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
3:33 PM
Dova Pharmaceuticals (Issuer)
Novak Alfred J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2019
3:06 PM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
3:48 PM
Dova Pharmaceuticals (Issuer)
Hoitt Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
6:07 AM
Dova Pharmaceuticals (Filer)
Form DEFA14A
03/15/2019
6:01 AM
Dova Pharmaceuticals (Filer)
Form DEF 14A
03/08/2019
7:46 AM
Dova Pharmaceuticals (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:15 AM
Dova Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2019
6:11 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
10:50 AM
Dova Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2019
4:26 PM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2019
4:00 PM
Dova Pharmaceuticals (Issuer)
Goldman Steven M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:59 PM
Dova Pharmaceuticals (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:57 PM
Dova Pharmaceuticals (Issuer)
Novak Alfred J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:55 PM
Dova Pharmaceuticals (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
4:03 PM
Dova Pharmaceuticals (Subject)
Manning Paul B (Filed by)
Form SC 13G/A
01/08/2019
4:01 PM
Dova Pharmaceuticals (Issuer)
Laliberte Kevin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:59 PM
Dova Pharmaceuticals (Issuer)
Hahn Mark W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:57 PM
ALLEN LEE F MD PhD (Reporting)
Dova Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
7:58 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2018
4:12 PM
Dova Pharmaceuticals (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:11 PM
Dova Pharmaceuticals (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:09 PM
Dova Pharmaceuticals (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:07 PM
Dova Pharmaceuticals (Issuer)
Stalfort Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:05 PM
Dova Pharmaceuticals (Issuer)
Hahn Mark W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
4:28 PM
Dova Pharmaceuticals (Issuer)
Manning Paul B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
4:27 PM
Dova Pharmaceuticals (Issuer)
Hoitt Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2018
4:25 PM
Dova Pharmaceuticals (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2018
4:24 PM
Dova Pharmaceuticals (Issuer)
Hoitt Jason (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2018
9:22 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2018
7:57 AM
Dova Pharmaceuticals (Filer)
Form CT ORDER
11/08/2018
3:31 PM
Dova Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2018
7:53 AM
Dova Pharmaceuticals (Issuer)
Hahn Mark W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2018
7:30 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
7:30 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2018
6:50 AM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2018
11:53 AM
Dova Pharmaceuticals (Filer)
Form CT ORDER
08/15/2018
3:27 PM
Dova Pharmaceuticals (Issuer)
Sapir Alex (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
6:46 AM
Dova Pharmaceuticals (Issuer)
Goldman Steven M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:19 PM
Dova Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
3:07 PM
Dova Pharmaceuticals (Filer)
Form 424B5
08/09/2018
3:06 PM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:06 PM
Dova Pharmaceuticals (Filer)
Form 424B5
08/08/2018
11:15 PM
Dova Pharmaceuticals (Filer)
Form EFFECT
07/27/2018
3:45 PM
Dova Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/27/2018
3:07 PM
Dova Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/27/2018
3:04 PM
Dova Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
3:59 PM
Dova Pharmaceuticals (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel